VITINA RUFFINO-MOSHER: Open Payments
NPI 1619030616 · FONDA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,429 in 72 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $1,339 · 2025 $1,429
Food & beverage: $1,429
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 15 | $374 |
| Otsuka America Pharmaceutical, Inc. | 14 | $169 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $103 |
| PFIZER INC. | 3 | $84 |
| ABBVIE INC. | 4 | $77 |
| Novo Nordisk Inc | 4 | $77 |
| Lilly USA, LLC | 3 | $71 |
| GlaxoSmithKline, LLC. | 4 | $65 |
| Lundbeck LLC | 3 | $65 |
| Amgen Inc. | 3 | $60 |
Products named: AIRSUPRA, REXULTI, CAPLYTA, ELIQUIS, KIDNEYINTELX BLOOD COLLECTION CONVENIENCE KIT, UBRELVY, Veozah, TRELEGY ELLIPTA.
Industry payments across NY — which companies pay providers there.
